相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Development and dynamics of robust T-cell responses to CML under imatinib treatment patients
Christiane I-U. Chen et al.
BLOOD (2008)
Dynamics and potential impact of the immune response to chronic myelogenous leukemia
Peter S. Kim et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Effect of Cellular Quiescence on the Success of Targeted CML Therapy
Natalia L. Komarova et al.
PLOS ONE (2007)
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia
Ellen Weisberg et al.
NATURE REVIEWS CANCER (2007)
Optimizing therapy of chronic myeloid leukemia
Michael W. N. Deininger
EXPERIMENTAL HEMATOLOGY (2007)
Comparison of imatinib, mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen:: high efficacy of drug combinations
Heather A. Bradeen et al.
BLOOD (2006)
Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications
Ingo Roeder et al.
NATURE MEDICINE (2006)
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Moshe Talpaz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Dynamics of chronic myeloid leukaemia
F Michor et al.
NATURE (2005)
Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance
HW Wang et al.
BLOOD (2005)
Overriding imatinib resistance with a novel ABL kinase inhibitor
NP Shah et al.
SCIENCE (2004)
Mechanisms and implications of imatinib resistance mutations in BCR-ABL
V Nardi et al.
CURRENT OPINION IN HEMATOLOGY (2004)
Specific targeted therapy of chronic myelogenous leukemia with imatinib
MWN Deininger et al.
PHARMACOLOGICAL REVIEWS (2003)
Boosting immunity by antiviral drug therapy: A simple relationship among timing, efficacy, and success
NL Komarova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
CB Gambacorti-Passerini et al.
LANCET ONCOLOGY (2003)
The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection
E Barnes et al.
HEPATOLOGY (2002)
Chronic myelogenous leukemia: mechanisms underlying disease progression
AS Shet et al.
LEUKEMIA (2002)
Helper-dependent vs. helper-independent CTL responses in HIV infection: Implications for drug therapy and resistance
D Wodarz
JOURNAL OF THEORETICAL BIOLOGY (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
JD Lifson et al.
JOURNAL OF VIROLOGY (2000)